Qube Research & Technologies LTD Cerus Corp Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Cerus Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 92,133 shares of CERS stock, worth $168,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,133Holding current value
$168,603% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding CERS
# of Institutions
149Shares Held
147MCall Options Held
191KPut Options Held
43.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.9MShares$36.4 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$35.6 Million0.46% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$25.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$19.2 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$15.7 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $324M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...